Introduction {#s0001}
============

Infectious diseases have been the cornerstone of human evolution. Before the development of modern hygiene practices, vaccines and antibiotics, the life expectancy was approximately 20 years, whereas today it is nearly 80 years (Siddle & Quintana-Murci [@CIT0028]). Since 1940, more than 335 infectious diseases have emerged, which are predominantly zoonoses (Jones et al. [@CIT0017]). Giardiasis is a re-emergent infectious disease that infects mammals, including humans (Thompson [@CIT0029]). The disease can be asymptomatic or present abdominal pain, diarrhoea, weight loss and nutrient malabsorption (Adam [@CIT0001]; Martínez-Gordillo et al. [@CIT0018]). *Giardia intestinalis* (Syn. *G. lamblia, G. duodenalis*) impairs children's physical and mental development (Berkman et al. [@CIT0004]; Eppig et al. [@CIT0010]). The World Health Organization (WHO) established that inhabitants of underdeveloped countries in Latin America, Asia and Africa experience 200 million infections yearly (Comité OMS d\'Experts [@CIT0008]). The metronidazole, tinidazole, albendazole, mebendazole, quinacrine, furazolidone and nitazoxanide are drugs against *Giardia*. However, these compounds produce undesirable secondary effects, such as hyporexia, nausea, abdominal discomfort, vertigo, mutagenic and carcinogenic effects (Ali & Nozaki [@CIT0002]; Rufino-González et al. [@CIT0023]). Additionally, the evolution of *Giardia* could give rise to resistant strains (Sangster et al. [@CIT0027]) and strains with the ability to live within the duodenal epithelium (Reynoso-Robles et al. [@CIT0021]). Therefore, it is imperative to search for new strategies for the treatment of giardiasis. Hence, we examined ethno-botanic and traditional medicines, and we found that *Piqueria trinervia* Cav. (Asteraceae) is a wild herbaceous plant with a wide distribution in the warm, dry and mild climates of Mexico (Rzedowski & Rzedowski [@CIT0025]). It is usually called 'hierba de San Nicolás' or 'hierba de tabardillo'. This plant has been used since the 16th century as an antipyretic and an antimalarial as well as to treat abdominal pain (Bejar et al. [@CIT0003]). Since 1970, different terpenes were isolated, such as piquerol A, piquerol B and carquejilo acetate (Romo et al. [@CIT0022]). Biologically, piquerol has allelopathic activity by preventing seed germination (González-Parra et al. [@CIT0011]). It was also used against snails, vectors of *Fasciola* and *Schistosoma* (Cruz-Reyes et al. [@CIT0009]), gravid female ticks (González-Parra et al. [@CIT0012]), *Trypanosoma cruzi* (Castro et al. [@CIT0007]) and pathogenic bacteria (Ruiz-Esparza et al. [@CIT0024]). Trinervinol has activity against fungi that parasitized plants (Saad et al. [@CIT0026]). In this work, it is reported the *in vitro* antigiardial activity of compounds from *P. trinervia*.

Materials {#s0002}
=========

Biological material {#s0003}
-------------------

*Piqueria trinervia* is a perennial herb that grows commonly in open areas of the pine oak forest of the mountains throughout Mexico and Central America.

The collection of *P. trinervia* was carried out in November 2010 in the Ajusco Mountain zone at 19° 15.042\' N and 99° 14.623\' W, of Mexico City, Mexico. Dr Jimenez deposited the vegetal material in the National Herbarium located at the Biology Institute of the National Autonomous University of Mexico. Dr Robert Bye identified the vegetal samples. The voucher specimen code number is MEXU1003. The *G. intestinalis* trophozoites were from the WB isolate GL50803 genotype A.

Fractionation and constituents {#s0004}
------------------------------

The plants were dried at ambient temperature then aerial parts were crushed and pulverized to increase the contact surface. We obtained the piquerol and trinervinol as described elsewhere (Romo et al. [@CIT0022]). The pulverized materials (760 g) was mixed with Millipore quality water for 24 h. Next, the materials was treated with dichloromethane following the procedures outlined by Ruiz-Esparza et al. ([@CIT0024]). The remaining solutions were designated as red oil (RO), fractions 1 and 2 (F1 and F2). Then the mentioned fractions were analysed in a preparative thin layer chromatography (TLC) plates and eluted with 1:1 hexane--ethyl acetate (EtOAc). The pattern of the bands was revealed with 1% cerium sulphate and by exposed to ultraviolet light (data not shown). The components of RO and F1 and F2 were identified by gas chromatography coupled to mass spectrometry (Joel GC-MS Mate II system, Shimadzu, Kyoto, Japan), equipped with an HP5-5Ms fused-silica capillary column (30 m × 0.25 mm). The GC oven temperature was programmed to increase at a rate of 8 °C min^−1^ until reaching 305 °C and held for 3 min.

The samples were dissolved in methanol and carried in helium. The electron impact technique (70 eV) was used to obtain the mass spectrum of the compounds in the fractions. The mass spectrum was continuously acquired from Total Ion Current (T.I.C.).

The GC-MS spectral data were digitalized, with the Mass Spectrum Digitizer program from the National Institute of Standards and Technology (NIST). The search performed in the MassBank of the Institute of Research and Development of Bioinformatics from the Japan Science, and Technology Agency and the Molecular Physiology of Plants Data Base Max Planck Institute (GMD_20111121_MDN35_ALK_MSP.txt).

Bioassays {#s0005}
---------

*Giardia intestinalis* (WB) trophozoites grew to confluence in a TYI-S-33 media, supplemented with bile and foetal calf serum. The culture tubes were chilled in an ice bath for 15 min to harvest *Giardia* trophozoites. The detached trophozoites were concentrated, transferred to Eppendorf tubes and washed three times with phosphate-buffered solution (PBS) pH 7.20. The size of the population was calculated using a Neubauer chamber and all assays were performed with 2 × 10^4^*Giardia* trophozoites. The compounds to test were dissolved in dimethyl sulfoxide (DMSO at 0.4%). Serial dilutions, from 200 to 0.78 μg/mL, were made with TYI-S-33 media and placed in 96-well culture plates to a final volume of 300 μL. Controls were untreated trophozoites, exposed to metronidazole and DMSO. The plates were incubated at 37 °C for 48 h, in an atmosphere containing 5% CO~2~ and 80% humidity. All manipulations were performed in a sterile environment in a vertical laminar flow cabinet. To assess viability the solution was removed by inversion (decantation), trophozoites were fixed with methanol and stained with methylene blue 0.1% for 15 min. The trophozoites were incubated for 30 min with 0.1 M hydrochloric acid at room temperature to extract the dye products. The concentration was determined at 650 nm (Busatti & Gomez [@CIT0006]; Houngkong et al. [@CIT0014]).

Toxicity test on Vero cells and human fibroblasts {#s0006}
-------------------------------------------------

The piquerol, trinervinol, fraction 2 and metronidazole were dissolved in DMSO, and performed toxicity assays at concentrations from 6.2 to 800 μg mL^−1^ on Vero cells \[(ATCC: CCL-81), from the green monkey kidney (*Cercopithecus aethiops*)\] and primary cultures of human fibroblasts. Vero cells or human fibroblasts grew in 25 mL tissue culture flasks with DMEM media (supplemented with 1X antibiotics-antimycotics, 1X [l]{.smallcaps}-glutamine and 10% foetal bovine serum) at 37 °C and 5% CO~2~. The cells grew up to confluence and then harvested, washed and counted in a Neubauer chamber. About 100 μL of medium containing 1.0 × 10^5^ Vero cells or human fibroblasts were seeded in a 96-well plate and incubated for 24 h, afterward; exposed to growing concentrations of the compounds (6.2--800 μg/mL) in 100 μL DMEM medium. The assay was repeated three times in triplicate. The negative controls were unexposed Vero cells, human fibroblasts and cells exposed to 0.2% DMSO. All experiments were incubated 48 h at 37 °C with 5% CO~2~. The cellular viability was assessed by the reduction of MTT-tetrazolium salts (3\[4,5-dimethylthiazol-2-y1\]-2,5-diphenyl-tetrazolium bromide) to formazan as described elsewhere (Ponce-Macotela et al. [@CIT0020]) with several modifications. Briefly, the treated cells (Vero or human fibroblasts) were concentrated by centrifugation; then we added 10 μL of MTT (5 mg/mL). Afterward, incubated at 37 °C for 4 h, and the formazan was solubilized overnight in 0.01 N HCl with 10% SDS in a final volume of 100 μL. The concentration of formazan was measured in a Uniskan spectrophotometer (Labsystem, Manchester, UK) at 570 nm.

Statistics {#s0007}
----------

All experiments were performed in a blinded fashion and repeated three times in triplicate. The trophozoites mortality and concentration was carried out, ANOVA and Tukey tests were conducted to compare *P. trinervia* compounds activity. Probit analysis was performed to calculate the IC~50~, IC~90~ and CC~50~ (concentration to reduce cell viability by 50%) at 95% confidence. The analysis was performed using the SPSS software (V 17.9) and JMP (V 9.0).

Results {#s0008}
=======

Fractions and constituents {#s0009}
--------------------------

The yield from the vegetal material was piquerol 1.52 g (0.2%), trinervinol 0.76 g (0.1) and red oil 8.36 g (1.1%). The TLC showed several bands, the RO, F1 and F2 samples were complex mixes ([Figure 1 Supplementary material](https://doi.org/10.1080/13880209.2017.1325912)). Patterns with 13 and 5 peaks for F1 and F2 were identified, the retention times were between 5 and 35 min. [Figure 1(A)](#F0001){ref-type="fig"}, which corresponds to F-1 and displays 13 compounds, shows that piquerol had a retention time of 12.22 min. In [Figure 1(B)](#F0001){ref-type="fig"}, in total five peaks were detected. Several compounds were identified based on their retention times and mass spectra using the database of the National Institute Standard and Technology (NIST) library software as follows: piquerol, 12.18; piquerinol, 13.03; and carquejol 13.35 min. The other peaks are probably piquerol isomers and other compounds, such as those identified by Ruiz-Esparza et al. ([@CIT0024]).

![GC/MS spectrum of the chemical constituents of F1 and F2 from *Piqueria trinervia*. (A) Fraction 1. The peak at 12.22 corresponds to piquerol. (B) Fraction 2. The peaks correspond to (a) piquerol, (b) piquerinol and (c) parquejol with retention times of 12.18, 13.03 and 13.35 min, respectively.](IPHB_A_1325912_F0001_B){#F0001}

Bioassay {#s0010}
--------

The [Table 1](#t0001){ref-type="table"} summarized the susceptibility of *Giardia* trophozoites to pure compounds and fractions from *P. trinervia*. The Probit analysis showed that trinervinol had the best antigiardial activity (IC~50~ = 2.03 μg/mL), followed of piquerol (IC~50~ = 2.42 μg/mL). A comparison between piquerol and trinervinol did not show statistical significance ([Table 2](#t0002){ref-type="table"}).

###### 

Fractions from *Piqueria trinervia* with antigiardiasic activity.

          Piquerol   Trinervinol   Red oil   F1       F2                                                                  
  ------- ---------- ------------- --------- -------- ------ --- -------- ------- --- -------- ------ --- -------- ------ ---
  3.125   37.4       3.42          A         46.65    5.35   A   25.983   2.51    A   30.267   6.63   A   35.15    6.94   A
  6.2     54.85      4.8           B         59.283   7.33   B   36.067   3.87    B   39.5     5.37   A   41.9     7.99   A
  12.5    80.8       5.65          C         74.733   6.5    C   47.2     6.85    C   51.2     6.16   B   54.067   5.75   B
  25      96.783     7.21          D         87.483   4.54   D   64.56    6.23    D   54.883   3.44   B   94.367   6.3    C
  50      98.633     3.34          D         99.05    2.32   E   80.45    5.94    E   89.083   6.72   C   96.817   7.79   C
  100     99.317     1.67          D         100      0      E   95.21    7.9     F   94.833   6.98   D   100      0      C
  200     100        0             D         100      0      E   99.95    0.122   F   100      0      D   100      0      C

Standard deviation.

Values not connected with the same letter are significantly different. *p* \< 0.001.

###### 

Probit test of compounds from *Piqueria trinervia*.

                IC~50~ (μg mL^−1^)   CL~95~[^a^](#TF3){ref-type="table-fn"}   IC~90~ (μg mL^−1^)   CL~95~
  ------------- -------------------- ---------------------------------------- -------------------- -----------------
  Piquerol      2.42                 (2.02--2.8)                              8.74                 (7.27--11.16)
  Trinervinol   2.03                 (1.51--2.54)                             13.03                (10.06--18.7)
  F2            3.38                 (1.46--5.66)                             14.75                (8.24--69.18)
  Red oil       5.66                 (4.64--6.79)                             46.45                (34.04--70.63)
  F1            5.03                 (2.57--8.18)                             37.32                (20.04--133.35)

Confidence limits at 95%.

Toxicity {#s0011}
--------

Determination of the cytotoxicity of *P. trinervia* compounds against mammal cells could be a significant step to advance in its use as antiparasitic. Trinervinol activity against Vero cells and human fibroblasts were negligible; CC~50~ was 278 and 590 μg/mL, respectively ([Table 3](#t0003){ref-type="table"}). The cytotoxicity of metronidazole on human fibroblasts was 452 μg/mL.

###### 

Cytotoxic analysis of compounds from *Piqueria trinervia* on Vero cells and human fibroblasts.

  Compounds       Vero cells CC50\*(CL95) μg mL^−1^   Fibroblasts CC50\*(CL95) μg mL^−1^
  --------------- ----------------------------------- ------------------------------------
  Piquerol        226 (139--336)                      501.44 (422.23--611.93)
  Trinervinol     278 (225--356)                      590 (544.23--645.81)
  Fraction 2      180 (28--287)                       348.21 (169.38--971.45)
  Metronidazole   475 (404--588)                      452.197 (417.32--493.99)

Discussion {#s0012}
==========

Both plants and animals have co-evolved in a complex web of interactions. Plants are the primary producers of the alimentary network and under selective pressure from grass-eaters. In response, plants evolved and developed a defence system based on secondary metabolites that protect them from herbivores, and also to facing infections from parasites, fungus, bacteria and viruses (Großkinsky et al. [@CIT0013]; Jeandet [@CIT0015]). Empirical observations since the first human societies were the touchstone to develop a pharmacology based on plant products; *P. trinervia* is a plant with a long ethnobotanical history. The new world societies used *Piqueria* as antipyretic and to treat abdominal pain, documented in the Florentine codex (Bejar et al. [@CIT0003]). Chemical studies on this plant began in the second half of the twentieth century.

Today antimicrobial resistance is becoming a worldwide problem owing to the paucity of research and development of new antibiotics, and because the indiscriminate usage of antibiotics is selecting resistant strains (O'Neill [@CIT0019]). The main difficulty is in bacteria. However, there is evidence of resistance in protozoa, helminths, virus and cancer cells. The history had shown that natural products are a source for the discovery of antibiotics. The antimicrobial resistance is prompting to looking back to the investigation of natural products (Brown & Wright [@CIT0005]).

Here, were presented evidence that *P. trinervia* has, at least, two promising compounds: trinervinol and piquerol, which were able to kill *G. intestinalis*. Since 2006, Ruíz-Esparza demonstrated antibacterial activity at concentrations ranging in mg mL^−1^. The piquerol dose (IC~50~ = 2.42 μg/mL) used against *Giardia* was 50 times lower than those reported against epimastigotes of *Trypanosoma cruzi* (Castro et al. [@CIT0007]). Additionally, it is necessary to annotate that the scaffold of pure compounds can be chemically modified, as was performed by Jiménez-Estrada et al. ([@CIT0016]). The piquerol is the compound more studied than trinervinol. However, data showing IC~50~ = 2.03 μg/mL on *G. intestinalis*, suggest that trinervinol must be investigated and modified to enhance its antigiardial activity. Reports as antifungal compound showed activity at 250 mg/mL on *Phoma macdonaldii* (Saad et al. [@CIT0026]) a very high concentration in comparison with the actual IC~50~ = 2.03 μg/mL on *G. intestinalis*.

The F1 and F2 were also able to eliminate *Giardia* trophozoites because these fractions had piquerol, piquerinol, carquejol, piquerol isomers and other compounds not yet biologically characterized ([Figure 1](#F0001){ref-type="fig"}).

Additionally, the pure compounds trinervinol and piquerol showed low toxicity on human fibroblasts with CC~50~ = 590 and 510 μg/mL, respectively, a value similar to metronidazole.

Conclusions {#s0013}
===========

The antigiardial activity of compounds from *P. trinervia* was demonstrated. Trinervinol and piquerol showed little toxicity on fibroblasts. In the era of antimicrobial resistance, the natural products can be a source of antibiotic substances. There are pending tasks that would enhance our results, such as chemically modifying purified metabolites and finding the targets of these molecules on *G. intestinalis* trophozoites.
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